In-tandem epitope binning of CD38-specific nanobodies and Dara scFv was performed on an Octet RED384 instrument (ForteBio). As running buffer HBS-EP + (0.01 M HEPES pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.05% v/v Surfactant P20) was used. Experiments were performed at 20 °C. The shake speed during the biosensor preparation and epitope binning was set at 1000 rpm. Amine reactive 2nd Generation (AR2G) biosensors (ForteBio) were activated for 10 min with EDC(20 mM)/NHS(10 mM) and human CD38 protein was loaded at 10 µg/ml in 10 mM sodium acetate pH6 for 15 min. After immobilization, surfaces were deactivated with 1 M ethanolamine (pH 8.5) for 10 min. In the epitope binning, 100 nM nanobody 1 was loaded during 3 min on immobilized CD38 to saturate all available epitopes. Nanobody 2 was presented after a 10 s dip in running buffer for 3 min followed by a 1 min dissociation. After each cycle the human CD38 surfaces were regenerated via 5 short pulses of 5 s each of 100 mM HCl followed by running buffer. Data was processed with ForteBio Data Analysis Software Version 9.0.0.12. Binding levels of nanobody 2 were determined at the end of the 3 min association and compared to levels at baseline (beginning of association). Irrelevant nanobody controls were included. The binding level of nanobody 2 for each nanobody 2 - nanobody 1 pair was divided by the binding response of nanobody 2 on a CD38 surface saturated with nanobody 2 (self-binning). Normalized data was hierarchically clustered using Ward’s method (distance measure: half square Euclidian distance; scale: logarithmic) and visualized in Spotfire (TIBCO Software Inc.).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.